Frontiers Of Medicine SCIE

國際簡(jiǎn)稱：FRONT MED-PRC 參考譯名：醫(yī)學(xué)前沿

主要研究方向：ONCOLOGYMEDICINE, RESEARCH & EXPERIMENTAL&-MEDICINE, RESEARCH & EXPERIMENTAL 非預(yù)警期刊審稿周期：

《醫(yī)學(xué)前沿》(Frontiers Of Medicine)是一本由Higher Education Press出版的以O(shè)NCOLOGYMEDICINE, RESEARCH & EXPERIMENTAL&-MEDICINE, RESEARCH & EXPERIMENTAL為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
77 年發(fā)文量
3.9 IF影響因子
未開放 是否OA
28 H-index
2007 創(chuàng)刊年份
6 issues per year 出版周期
English 出版語言

Frontiers of Medicine is an international general medical journal sponsored by the Ministry of Education of China. The journal is jointly published by the Higher Education Press and Springer. Online versions are available through http://link.springer.com/. Since the first issue of 2010, this journal has been indexed in PubMed/MEDLINE.

Frontiers of Medicine is dedicated to publishing original research and review articles on the latest advances in clinical and basic medicine with a focus on epidemiology, traditional Chinese medicine, translational research, healthcare, public health and health policies. The journal employs a rigorous peer-review and editing process to ensure the scientific accuracy, novelty and importance of the manuscripts. Frontiers of Medicine is committed to promoting health and health care through communications among professionals in medical care, disease prevention and scientific research throughout the world by updating the progress in medicine, sharing experiences in disease control and treatment and exchanging views on health policies, medical services and health care reform.

[ 查看全部 ]

投稿咨詢加急咨詢

Frontiers Of Medicine期刊信息

ISSN：2095-0217
出版語言：English
是否OA：未開放
E-ISSN：2095-0225
出版地區(qū)：PEOPLES R CHINA
是否預(yù)警：否
出版商：Higher Education Press
出版周期：6 issues per year
創(chuàng)刊時(shí)間：2007
開源占比：0.1362
Gold OA文章占比：9.22%
OA被引用占比：0.4922...
出版國人文章占比：0.73
出版撤稿占比：0
研究類文章占比：72.73%

Frontiers Of Medicine CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

18.3

1.468

1.265

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：General Medicine	Q1	17 / 636	97%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Frontiers Of Medicine中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) ONCOLOGY 腫瘤學(xué)	3區(qū) 4區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) ONCOLOGY 腫瘤學(xué)	2區(qū) 2區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) ONCOLOGY 腫瘤學(xué)	3區(qū) 3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) ONCOLOGY 腫瘤學(xué)	3區(qū) 3區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) ONCOLOGY 腫瘤學(xué)	3區(qū) 3區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) ONCOLOGY 腫瘤學(xué)	3區(qū) 3區(qū)

Frontiers Of Medicine JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	64 / 189	66.4%
學(xué)科：ONCOLOGY	SCIE	Q2	99 / 322	69.4%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q2	64 / 189	66.4%
學(xué)科：ONCOLOGY	SCIE	Q2	102 / 322	68.48%

Frontiers Of Medicine歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Frontiers Of Medicine中國學(xué)者發(fā)文選摘

1、CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
Author: Yu, Wei-Bang; Chen, Yu-Chi; Huang, Can-Yu; Ye, Zi-Han; Shi, Wei; Zhu, Hong; Shi, Jia-Jie; Chen, Jun; Lu, Jin-Jian

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 105-118. DOI: 10.1007/s11684-022-0934-1
2、RGS16 regulated by let-7c-5p promotes glioma progression by activating PI3K-AKT pathway
Author: Wang, Chaochao; Xue, Hao; Zhao, Rongrong; Sun, Zhongzheng; Gao, Xiao; Qi, Yanhua; Wang, Huizhi; Xu, Jianye; Deng, Lin; Li, Gang

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 143-155. DOI: 10.1007/s11684-022-0929-y
3、Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
Author: Weng, Danhui; Xiong, Huihua; Zhu, Changkun; Wan, Xiaoyun; Chen, Yaxia; Wang, Xinyu; Zhang, Youzhong; Jiang, Jie; Zhang, Xi; Gao, Qinglei; Chen, Gang; Xing, Hui; Wang, Changyu; Li, Kezhen; Chen, Yaheng; Mao, Yuyan; Hu, Dongxiao; Pan, Zimin; Chen, Qingqin; Cui, Baoxia; Song, Kun; Yi, Cunjian; Peng, Guangcai; Han, Xiaobing; An, Ruifang; Fan, Liangsheng; Wang, Wei; Xiong, Tingchuan; Chen, Yile; Tang, Zhenzi; Li, Lin; Yang, Xingsheng; Cheng, Xiaodong; Lu, Weiguo; Wang, Hui; Kong, Beihua; Xie, Xing; Ma, Ding

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 93-104. DOI: 10.1007/s11684-021-0892-z
4、Achievements of the national malaria control and elimination program in the People's Republic of China: the Atlas of Malaria Transmission in China
Author: Feng, Jun; Zhang, Li; Xia, Zhigui; Zhou, Shuisen; Xiao, Ning; Zhou, Xiao-Nong

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 85-92. DOI: 10.1007/s11684-021-0917-7
5、GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma
Author: Du, Yingxi; Ma, Yarui; Zhu, Qing; Fu, Yong; Li, Yutong; Zhang, Ying; Li, Mo; Feng, Feiyue; Yuan, Peng; Wang, Xiaobing

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 119-131. DOI: 10.1007/s11684-022-0949-7
6、Association of cardiac disease with the risk of post-lung transplantation mortality in Chinese recipients aged over 65 years
Author: Jiao, Guohui; Ye, Shugao; Zhang, Ji; Wu, Bo; Wei, Dong; Liu, Dong; Liu, Feng; Hu, Chunxiao; Chen, Jingyu

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 58-67. DOI: 10.1007/s11684-022-0937-y
7、Decreasing complexity of glucose time series derived from continuous glucose monitoring is correlated with deteriorating glucose regulation
Author: Li, Cheng; Ma, Xiaojing; Lu, Jingyi; Tao, Rui; Yu, Xia; Mo, Yifei; Lu, Wei; Bao, Yuqian; Zhou, Jian; Jia, Weiping

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 68-74. DOI: 10.1007/s11684-022-0955-9
8、J-shaped association between dietary zinc intake and new-onset hypertension: a nationwide cohort study in China
Author: He, Panpan; Li, Huan; Liu, Mengyi; Zhang, Zhuxian; Zhang, Yuanyuan; Zhou, Chun; Ye, Ziliang; Wu, Qimeng; Liang, Min; Jiang, Jianping; Wang, Guobao; Nie, Jing; Hou, Fan Fan; Liu, Chengzhang; Qin, Xianhui

Journal: FRONTIERS OF MEDICINE. 2023; Vol. 17, Issue 1, pp. 156-164. DOI: 10.1007/s11684-022-0932-3